BRN (ASX) 2023 BrainChip Discussion

BRN

Click for more information

2.94%

17.5¢ brainchip holdings ltd

First 2947 Last

Share
Profile

Follow
mapp

1,964 Posts.

295

26/07/23

00:39

Post #: 68979420
Share

Originally posted by mapp: ↑

And on call Jimmy the BRN spruiker chips in

Why is the Brainchip share price sinking 4% today?
Brainchip had yet another deflating quarter.

James Mickleboro❯
Published July 24, 11:18 am
The Brainchip Holdings Ltd (ASX: BRN) share price has taken a tumble on Monday.
In morning trade, the struggling semiconductor company’s shares are down 4% to 36 cents.
This latest decline means the Brainchip share price is now down 69% over the last 12 months.
Why is the Brainchip share price falling again on Monday?
Investors have been selling down Brainchip shares today after the company released yet another underwhelming quarterly update.
For the three months ended 30 June, the $660 million semiconductor company reported cash receipts of just US$0.8 million.
This continues to be far less than the company spends on its operating activities, which led to an operating cash outflow of US$4.1 million.
But thanks to its ongoing quasi-capital raising arrangement with LDA Capital, which pulled in US$8.1 million while further diluting shareholders, Brainchip finished the period with a cash balance of US$21.8 million. This is up from US$17.7 million at the end of March.
What happened during the quarter?
Not much! There was a lot of style but no real substance during the three months.
Nevertheless, in his CEO statement, Brainchip leader Sean Hehir sounded as positive as ever on the future. He said:
However, it is worth highlighting that this sort of statement has been thrown around a lot in the past by Hehir. And we all saw how that turned out in respect to sales.
The company also highlights the hard work it has been doing on its podcasts. Brainchip now has two podcasts receiving hundreds of listens each month.
Overall, not a lot to report on this quarter. But with its new tech released shortly, investors will soon find out if the second generation Akida platform is a success or a flop like the first generation offering.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Expand

is this what you are talking about

Originally posted by noramando: ↑

Sean Hehir is the worst car salesman and the best con artist. Ever!!

https://www.********.au/2023/07/24/why-is-the-brainchip-share-price-sinking-4-today/

Whether one likes this article or not. It bears a certain degree of truth and at least someone is willingly to speak out and post it.

Expand

BRN Price at posting: 35.5¢ Sentiment: Buy Disclosure: Held
Upvote

1 Great analysis

Reply

Top Stories

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Emerald & Azure score Digger & Dealer awards

Revolutionary inverter technology leads the clean energy charge

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Bitcoin: Current State of Play & Where to Next | Swyftx

There are more pages in this discussion • 3,449 more messages in this thread...

First 2947 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 17.5¢		Change 0.005(2.94%)		Mkt cap ! $342.8M

Open	High	Low	Value	Volume
17.5¢	18.0¢	17.0¢	$737.6K	4.203M

Buyers (Bids)

No.	Vol.	Price($)
69	1587304	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
17.5¢	213251	4

View Market Depth

No.	Vol.	Price($)
61	1360417	0.170
42	704394	0.165
64	1394316	0.160
22	951201	0.155
65	1747465	0.150

Price($)	Vol.	No.
0.175	116715	2
0.180	1076124	22
0.185	880560	25
0.190	1431809	21
0.195	984971	15

Last trade - 16.10pm 09/08/2024 (20 minute delay)

BRN (ASX) Chart

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

True North increases silver metal at QLD's Vero deposit by 20%

Emerald & Azure score Digger & Dealer awards

Revolutionary inverter technology leads the clean energy charge

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Bitcoin: Current State of Play & Where to Next | Swyftx

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Top Stories

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

True North increases silver metal at QLD's Vero deposit by 20%

Emerald & Azure score Digger & Dealer awards

Revolutionary inverter technology leads the clean energy charge

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Bitcoin: Current State of Play & Where to Next | Swyftx

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News